GlassScriptPhysician profile
Amanda Wills
NPI 1720526379
$8,370.90
in general payments reported to CMS, 2019-2025
38 companies · $2,460 in 2025
The $2,460 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $208 · 2022: $283 · 2023: $2,476 · 2024: $2,943 · 2025: $2,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,847 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,847.17 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,226.24 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $1,004.37 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $642.28 | 2023-2025 | |
| Corcept Therapeutics | $491.21 | 2023-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $481.14 | 2022-2025 | |
| Amgen INC. | $394.87 | 2022-2025 | Repatha, Evenity, Prolia |
| Ibsa Pharma INC. | $390.22 | 2022-2025 | Tirosint, Licart, Tirosint |
| Antares Pharma, INC. | $388.73 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Abbott Laboratories | $348.31 | 2024-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $296.06 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Ascendis Pharma Endocrinology INC | $263.54 | 2023-2025 | Yorvipath |
| Insulet Corporation | $253.93 | 2023-2025 | Omnipod |
| Radius Health, INC. | $245.72 | 2022-2025 | Tymlos |
| Amneal Pharmaceuticals LLC | $242.94 | 2023-2025 | Unithroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.85 | 2021-2025 | Jardiance |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $225.11 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astrazeneca Pharmaceuticals LP | $152.00 | 2021-2025 | Farxiga, Lokelma |
| Kyowa Kirin, INC. | $126.37 | 2023-2025 | Crysvita |
| Abbvie INC. | $107.52 | 2021-2024 | |
| Pfizer INC. | $102.49 | 2023-2024 | |
| Cequr Corporation | $83.62 | 2023-2025 | Cequr Simplicity |
| Esperion Therapeutics, INC. | $79.47 | 2024-2025 | Nexletol |
| Mannkind Corporation | $63.60 | 2025 | |
| Chiesi USA, INC. | $57.76 | 2024-2025 | Mycapssa |
| Ascensia Diabetes Care US INC. | $56.76 | 2023-2024 | |
| Halozyme INC | $55.00 | 2023 | |
| Tolmar, INC. | $54.16 | 2025 | Jatenzo |
| Amarin Pharma, INC. | $42.12 | 2021-2023 | |
| Azurity Pharmaceuticals, INC. | $39.19 | 2023-2025 | Azmiro, Adthyza |
| Novartis Pharmaceuticals Corporation | $37.05 | 2025 | |
| Astellas Pharma US INC | $33.99 | 2024-2025 | Veozah |
| Sequel Med Tech, LLC | $31.92 | 2025 | Twiist |
| Recordati_rare_diseases_inc. | $28.56 | 2025 | Isturisa |
| Averitas Pharma INC. | $24.25 | 2023 | Qutenza |
| Beta Bionics, INC. | $21.05 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Horizon Therapeutics Plc | $17.30 | 2023 | Tepezza |
| Almatica Pharma LLC | $17.28 | 2024 | Teriparatide |
| Acella Pharmaceuticals, LLC | $13.92 | 2024 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Wills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.